Rubraca Interactions
There are 733 drugs known to interact with Rubraca (rucaparib), along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 119 are major, 599 are moderate, and 15 are minor.
- View all 733 medications that may interact with Rubraca
- View Rubraca alcohol/food interactions (1)
- View Rubraca disease interactions (3)
Most frequently checked interactions
View interaction reports for Rubraca (rucaparib) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adderall (amphetamine / dextroamphetamine)
- Adderall XR (amphetamine / dextroamphetamine)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Aleve (naproxen)
- ambrisentan
- Amondys 45 (casimersen)
- anastrozole
- apremilast
- Aspir 81 (aspirin)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Avastin (bevacizumab)
- Bafiertam (monomethyl fumarate)
- Benadryl (diphenhydramine)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blincyto (blinatumomab)
- bosentan
- Braftovi (encorafenib)
- Breyanzi (lisocabtagene maraleucel)
- Brilinta (ticagrelor)
- Mekinist (trametinib)
- ondansetron
- Vitamin D3 (cholecalciferol)
Rubraca alcohol/food interactions
There is 1 alcohol/food interaction with Rubraca (rucaparib).
Rubraca disease interactions
There are 3 disease interactions with Rubraca (rucaparib) which include:
Report options
QR code containing a link to this page
More about Rubraca (rucaparib)
- Rubraca consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PARP inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
